91 related articles for article (PubMed ID: 18061458)
1. Protein phosphatase inhibitory activity of tautomycin photoaffinity probes evaluated at femto-molar level.
Sydnes MO; Kuse M; Kurono M; Shimomura A; Ohinata H; Takai A; Isobe M
Bioorg Med Chem; 2008 Feb; 16(4):1747-55. PubMed ID: 18061458
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of tautomycin and related compounds against Sclerotinia sclerotiorum.
Chen X; Zhu X; Ding Y; Shen Y
J Antibiot (Tokyo); 2011 Aug; 64(8):563-9. PubMed ID: 21772304
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity.
Ju J; Li W; Yuan Q; Peters NR; Hoffmann FM; Rajski SR; Osada H; Shen B
Org Lett; 2009 Apr; 11(7):1639-42. PubMed ID: 19281218
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of [18,19,21,22-(13)C4]-labeled tautomycin as an NMR probe of protein phosphatase inhibitor.
Isobe M; Kurono M; Tsuboi K; Takai A
Chem Asian J; 2007 Mar; 2(3):377-85. PubMed ID: 17441173
[TBL] [Abstract][Full Text] [Related]
5. Tautomycin's interactions with protein phosphatase 1.
Sydnes MO; Isobe M
Chem Asian J; 2010 Mar; 5(3):410-20. PubMed ID: 20013999
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of specific protein phosphatase inhibitors, tautomycin and tautomycetin toward structure-activity relationship study.
Oikawa H
Curr Med Chem; 2002 Nov; 9(22):2033-53. PubMed ID: 12369869
[TBL] [Abstract][Full Text] [Related]
7. Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis.
Kawamura T; Matsuzawa S; Mizuno Y; Kikuchi K; Oikawa H; Oikawa M; Ubukata M; Ichihara A
Biochem Pharmacol; 1998 Apr; 55(7):995-1003. PubMed ID: 9605423
[TBL] [Abstract][Full Text] [Related]
8. The apoptosis-inducing activity of the two protein phosphatase inhibitors, tautomycin and thyrsiferyl 23-acetate, is not due to the inhibition of protein phosphatases PP1 and PP2A (review).
Kikuchi K; Shima H; Mitsuhashi S; Suzuki M; Oikawa H
Int J Mol Med; 1999 Oct; 4(4):395-401. PubMed ID: 10493981
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of lipoic acid on firefly luciferase bioluminescence.
Niwa K; Ohmiya Y
Biochem Biophys Res Commun; 2004 Oct; 323(2):625-9. PubMed ID: 15369796
[TBL] [Abstract][Full Text] [Related]
10. A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.
Ubukata M; Koshino H; Yamasaki C; Fujita K; Isono K
J Antibiot (Tokyo); 1997 Oct; 50(10):801-7. PubMed ID: 9402983
[No Abstract] [Full Text] [Related]
11. Synthesis of a C1-C21 subunit of the protein phosphatase inhibitor tautomycin: a formal total synthesis.
Marshall JA; Yanik MM
J Org Chem; 2001 Feb; 66(4):1373-9. PubMed ID: 11312969
[TBL] [Abstract][Full Text] [Related]
12. The selective inhibition of phosphatases by natural toxins: the anhydride domain of tautomycin is not a primary factor in controlling PP1/PP2A selectivity.
Liu W; Sheppeck JE; Colby DA; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem Lett; 2003 May; 13(9):1597-600. PubMed ID: 12699763
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship within a series of degradation products of tautomycin.
Nishiyama U; Ubukata M; Magae J; Kataoka T; Erdödi F; Hartshorne DJ; Isono K; Nagai K; Osada H
Biosci Biotechnol Biochem; 1996 Jan; 60(1):103-7. PubMed ID: 8824829
[TBL] [Abstract][Full Text] [Related]
14. Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.
Adler JT; Cook M; Luo Y; Pitt SC; Ju J; Li W; Shen B; Kunnimalaiyaan M; Chen H
Mol Cancer Ther; 2009 Apr; 8(4):914-20. PubMed ID: 19372564
[TBL] [Abstract][Full Text] [Related]
15. A new model of the tautomycin-PP1 complex that is not analogous to the corresponding okadaic acid structure.
Colby DA; Liu W; Sheppeck JE; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem Lett; 2003 May; 13(9):1601-5. PubMed ID: 12699764
[TBL] [Abstract][Full Text] [Related]
16. Morphological changes and reorganization of actinfilaments in human myeloid leukemia cells induced by a novel protein phosphatase inhibitor, tautomycin.
Kurisaki T; Magae J; Nagai K; Hirata A; Kusaka I; Shinji H; Morikawa M; Yoshida T; Isono K; Yamasaki M
Cell Struct Funct; 1993 Feb; 18(1):33-9. PubMed ID: 8389250
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis of dinophysistoxin-2 and 2-epi-dinophysistoxin-2 and their PPase inhibition.
Pang Y; Fang C; Twiner MJ; Miles CO; Forsyth CJ
Angew Chem Int Ed Engl; 2011 Aug; 50(33):7631-5. PubMed ID: 21726026
[No Abstract] [Full Text] [Related]
18. Development of bifunctional photoactivatable benzophenone probes and their application to glycoside substrates.
Qvit N; Monderer-Rothkoff G; Ido A; Shalev DE; Amster-Choder O; Gilon C
Biopolymers; 2008; 90(4):526-36. PubMed ID: 18459171
[TBL] [Abstract][Full Text] [Related]
19. [Total synthesis and conformational analysis of inhibitors].
Tsuboi K; Isobe M
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1083-90. PubMed ID: 9655966
[No Abstract] [Full Text] [Related]
20. The spiroketals containing a benzyloxymethyl moiety at C8 position showed the most potent apoptosis-inducing activity.
Mitsuhashi S; Shima H; Kawamura T; Kikuchi K; Oikawa M; Ichihara A; Oikawa H
Bioorg Med Chem Lett; 1999 Jul; 9(14):2007-12. PubMed ID: 10450971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
